Screener
Kymera Therapeutics KYMR Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Kymera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Accounts payable | $8,918 | $4,015 |
| Accrued expenses (Note 8) | 48,476 | 42,274 |
| Deferred revenue | — | 22,925 |
| Operating lease liabilities | 12,119 | 11,941 |
| Finance lease liabilities | 1,577 | 1,815 |
| Other current liabilities | 236 | 242 |
| Total current liabilities | $71,326 | $83,212 |
| Non-current liabilities |
Item 1. Financial Statements.
FAQ
- What is Kymera Therapeutics's operating lease liabilities (current)?
- Kymera Therapeutics (KYMR) reported operating lease liabilities (current) of $12.12M in Q2 2026.
- How has Kymera Therapeutics's operating lease liabilities (current) changed year-over-year?
- Kymera Therapeutics's operating lease liabilities (current) increased by 3.0% year-over-year, from $11.77M to $12.12M.
- What is the long-term trend for Kymera Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Kymera Therapeutics's operating lease liabilities (current) has grown at a 35.9% compound annual growth rate (CAGR), from $2.57M to $11.94M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Kymera Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude